Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control
Open Access
- 1 January 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in Filaria Journal
- Vol. 3 (1), 7
- https://doi.org/10.1186/1475-2883-3-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported casesFilaria Journal, 2003
- Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in CameroonFilaria Journal, 2003
- Effects of a 3-day regimen of albendazole (800 mg daily) onLoa loamicrofilaraemiaPathogens and Global Health, 2002
- Effect of a single dose (600 mg) of albendazole onLoa loamicrofilaraemiaParasite, 2002
- Encephalopathy following Loa loa treatment with albendazoleActa Tropica, 2001
- Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis.The American Journal of Tropical Medicine and Hygiene, 1998
- Challenges for the future: loiasis.Pathogens and Global Health, 1998
- Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infectionThe Lancet, 1997
- Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areasParasitology Today, 1996
- Albendazole in Human Loiasis: Results of a Double-Blind, Placebo-Controlled TrialThe Journal of Infectious Diseases, 1993